Compass Therapeutics Inc (CMPX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CMPX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Compass Therapeutics Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent35.45
Marketable Securities, Current SH144.43
Cash & Short-term Investments179.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.01
Total Current Assets180.89
Equipment/Property/Plant Net6.91
Long-term investments0.57
Other Assets, Noncurrent1.80
Operating Lease Right Of Use Asset8.75
Total Assets190.17
Liabilities
Accounts Payable, Current AC2.91
Accrued Liabilities, Current AC11.59
Other Liabilities, Current1.64
Total Current Liabilities16.13
Total Long-term Debt0.00
Other liabilities, Noncurrent8.00
OperatingLeaseLiabilityNoncurrent8.42
Operating Lease Liability Current1.37
Total Liabilities24.12
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock640.93
Retained Earnings / Accumulated Deficit-474.64
Accumulated Other Comprehensive Income-0.25
Other Equity-0.25
Common Stockholder's Equity166.05
Total Stockholder's Equity166.05
Liabilities & Stockholder's Equity190.17
4 historic quarters locked

Sign in to unlock the full Compass Therapeutics Inc balance sheet history.

About Compass Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001171843-26-005295

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.